Affiliation:
1. Department of Urology Rush University Chicago Illinois USA
2. Department of Maternal‐Child and Urological Sciences Sapienza University Rome Policlinico Umberto I Hospital Rome Italy
3. Department of Urology “Regina Elena” National Cancer Institute Rome Italy
4. Department of Urology University of Louisville School of Medicine Louisville Kentucky USA
5. Unit of Urology, Department of Woman, Child and General and Specialized Surgery University of Campania “Luigi Vanvitelli” Naples Italy
Abstract
AbstractBackgroundPriapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large‐scale research focused on patient characteristics and management strategies.ObjectivesTo analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI).Materials and methodsWe performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010–2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis.ResultsOf 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05).ConclusionMost cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.
Reference33 articles.
1. SaloniaA BettocchiC CarvalhoJ CoronaG JonesTH KadiogluA.European Association of Urology Guidelines on Sexual and Reproductive Health.2023. Accessed February 2024.https://uroweb.org/guidelines/sexual‐and‐reproductive‐health/chapter/priapism
2. Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences
3. The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline
4. Priapism: what cause: mental illness, psychotropic medications or poly‐substance abuse?;Khan QS;J Okla State Med Assoc,2016
5. Treatment of Priapism Secondary to Drugs for Erectile Dysfunction